Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Recruiting

I'm Interested

Trial ID: NCT04383808

Age - 21 Years-N/A Gender - ALL Accepting Healthy Volunteers - yes

Purpose

The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.

Official Title

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Stanford Investigator(s)

Guido A. Davidzon
Guido A. Davidzon

Clinical Professor, Radiology - Rad/Nuclear Medicine

Eligibility

Inclusion Criteria:

1. Whole body radiation dose within the last year of less than 5000 mrem
2. Subjects intended for injected tracer studies (not associated with another study) must be willing/able to undergo injection of 6-12 mCi of either FDG or Neuraceq radiotracer. Both tracers are FDA approved
3. Subjects will be at least 21 years of age
4. Subject provides written informed consent
5. Subject is deemed healthy by the PI by via self-reported questionnaire

Exclusion Criteria:

1. For patients who will be receiving a tracer injection, no known allergy to the imaging agents
2. Participant has a history of or current diagnosis of cancer
3. Participant is pregnant or nursing
4. Metallic implants (contraindicated for MRI)

View More
View Less

Intervention(s):

diagnostic_test: Injected radiotracer with PET Insert

diagnostic_test: Pre-injected group with PET insert

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Paul Newswanger, MPH
650-736-1349

©2025 Stanford Medicine